Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Document Type
- Journal article (12) (remove)
Language
- English (12) (remove)
Keywords
- cerebrospinal fluid (5)
- forensic neuropathology (5)
- biomarker (4)
- forensic neurotraumatology (4)
- immunohistochemistry (3)
- CSF (2)
- Anti-tank rocket (1)
- Anti-tank weapon (1)
- Ballistics (1)
- CA4 (1)
- Davis gun (1)
- Forensische Anthropologie (1)
- Forensische Osteologie (1)
- Geschlechtsbestimmung (1)
- IDH1/2 (1)
- Identifizierung (1)
- Landmarken (1)
- Military shooting (1)
- SOAT1 (1)
- astrocytoma (1)
- biofluid (1)
- biomarker combination (1)
- creatine kinase (1)
- dentate gyrus (1)
- drug abuse (1)
- electrocution (1)
- fatal traumatic brain injury (1)
- forensic anthropology (1)
- forensic osteology (1)
- gender (1)
- glial fibrillary acidic protein (1)
- glioblastoma (1)
- hippocampus (1)
- identification (1)
- immunocytochemistry (1)
- interleukin-6 (1)
- intramuscular hemorrhage (1)
- landmarks (1)
- layered dissection (1)
- lipid droplets (1)
- metabolomics (1)
- microglia (1)
- mitotane (1)
- neuroinflammation (1)
- neuron (1)
- neurotoxicity (1)
- oligodendrocyte (1)
- post mortem biochemistry (1)
- postmortem (1)
- postmortem biochemistry (1)
- schizophrenia (1)
- stereology (1)
- targeted therapy (1)
- tetany (1)
- traumatic brain injury (1)
Institute
- Institut für Rechtsmedizin (12) (remove)
In the last few years, quantitative analysis of metabolites in body fluids using LC/MS has become an established method in laboratory medicine and toxicology. By preparing metabolite profiles in biological specimens, we are able to understand pathophysiological mechanisms at the biochemical and thus the functional level. An innovative investigative method, which has not yet been used widely in the forensic context, is to use the clinical application of metabolomics. In a metabolomic analysis of 41 samples of postmortem cerebrospinal fluid (CSF) samples divided into cohorts of four different causes of death, namely, cardiovascular fatalities, isoIated torso trauma, traumatic brain injury, and multi-organ failure, we were able to identify relevant differences in the metabolite profile between these individual groups. According to this preliminary assessment, we assume that information on biochemical processes is not gained by differences in the concentration of individual metabolites in CSF, but by a combination of differently distributed metabolites forming the perspective of a new generation of biomarkers for diagnosing (fatal) TBI and associated neuropathological changes in the CNS using CSF samples.
The aim of this pilot study was to investigate the diagnostic potential of TMEM119 as a useful microglia-specific marker in combination with immunostainings for phagocytic function and infiltrating capacity of monocytes in cases of lethal monosubstance intoxications by morphine (MOR), methamphetamine (METH), and of ethanol-associated death (ETH) respectively. Human brain tissue samples were obtained from forensic autopsies of cases with single substance abuse (MOR, n = 8; ETH, n = 10; METH, n = 9) and then compared to a cohort of cardiovascular fatalities as controls (n = 9). Brain tissue samples of cortex, white matter, and hippocampus were collected and stained immunohistochemically with antibodies against TMEM119, CD68KiM1P, and CCR2. We could document the lowest density of TMEM119-positive cells in MOR deaths with highly significant differences to the control densities in all three regions investigated. In ETH and METH deaths, the expression of TMEM119 was comparable to cell densities in controls. The results indicate that the immunoreaction in brain tissue is different in these groups depending on the drug type used for abuse.